Dr Colin Hopper, Associate Clinical Professor at University College London, President of the International Photodynamic Association, and world-leading expert on photodynamic therapy (also known as ...
FDA approves new oral antibiotic for uncomplicated urinary tract infections in women with limited treatment options. Orylnvah shows superior response rates ...
Not much went right for Spero Therapeutics’ SPR720 in its phase 2a trial. | Not much went right for Spero Therapeutics’ SPR720 in its phase 2a trial. An interim analysis revealed a double blow to the ...
The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.